Login

Ownership

13F as of Q2 2026 · 75.3M shares outstanding

Who owns SpringWorks Therapeutics, Inc.?

By type of holder
Institutions 0.0% Everyone else 100.0%

No insider has reported a holding in the last two years, so insiders are counted in "Everyone else".

Concentration Top 1 holders own 0.0%
Huntington National Bank 0.0%
Institutional ownership
0.0%
0.0 pts vs last qtr
Institutional holders
1
0 vs last qtr
Net shares bought
0
by institutions in Q2 2026
New / sold out
0 / 0
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

None.

Biggest sellers in Q2 2026

None.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for SpringWorks Therapeutics, Inc. in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2019–FY2024
+458.4%
+41.06% a year
Each share's claim on the business
−82.1%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
$12.6M vs $328M
over 6 fiscal years
Diluted shares, split-adjusted
12.9M43.9M74.9M2019: 13.3M shares'192020: 43.3M shares'202021: 48.5M shares'212022: 53.3M shares'222023: 63.1M shares'232024: 74.1M shares'24
Buybacks Stock-based comp
$0$54.6M$109.1M2019 buybacks: $02019 stock comp: $3.1M'192020 buybacks: $02020 stock comp: $10.0M'202021 buybacks: $02021 stock comp: $38.4M'212022 buybacks: $1.3M2022 stock comp: $73.0M'222023 buybacks: $2.8M2023 stock comp: $94.5M'232024 buybacks: $8.4M2024 stock comp: $109.1M'24

How patient are the owners?

Institutional shares by how long they've been held
5+ years0% 3–5 years0% 1–3 years100% Under 1 year0%
Quarterly turnover
0.0%
of institutional shares changed hands
Top 10 managers, median time held
2 years

Super Investors

Investment managers reporting SpringWorks Therapeutics, Inc. on Form 13F
HN
Huntington National Bank
Shares
1
% of company
0.00%
Change vs last qtr
Unchanged
Held since
2024

Institutional Funds

Mutual funds and ETFs reporting SpringWorks Therapeutics, Inc. on Form N-PORT; together they hold 47.0% of the company
FG
Fidelity Mt. Vernon Street Trust
Position value
$205M
% of company
4.72%
% of the fund
0.31%
As of
February 28, 2025
VT
Position value
$109M
% of company
3.07%
% of the fund
0.01%
As of
June 30, 2025

23 more funds behind a free account

See every fund holding SpringWorks Therapeutics, Inc. and how much of the fund the position is.

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support